acetyl coenzyme a has been researched along with Non-alcoholic Fatty Liver Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 10 (76.92) | 2.80 |
| Authors | Studies |
|---|---|
| Assante, G; Ballard, JWO; Banks, JL; Campbell, P; Chandrasekaran, S; Chokshi, S; Chung, CH; Dhawan, A; Filippi, C; Hoare, M; Isse, KA; Liu, M; Morris, MJ; Ng, S; Rozen, SG; Soffientini, U; Tourna, A; Turner, N; Youngson, NA | 1 |
| Luo, G; Xiang, L; Xiao, L | 1 |
| Dai, W; Guo, W; Hu, L; Lee, WX; Li, M; Liu, X; Liu, Y; Lu, Q; Tan, J; Tang, HW; Wang, W; Wang, Y; Zhou, Q | 1 |
| Albanese, C; Avantaggiati, ML; Catalina-Rodriguez, O; Cheema, A; Foley, P; Gadre, S; Giaccone, G; Graham, GT; Kallakury, B; Kasprzyk-Pawelec, A; Mosaoa, R; Parasido, E; Tan, M; Yi, C | 1 |
| Brill, AL; Butrico, GM; Cline, GW; Dufour, S; Ehrlich, BE; Goedeke, L; Guerra, MT; Nasiri, AR; Nathanson, MH; Nozaki, Y; Peng, L; Perry, RJ; Petersen, KF; Rabin-Court, A; Shulman, GI; Toussaint, K; Wang, Y; Zhang, D; Zhang, XM; Zhang, Y | 1 |
| Ceteci, F; Conche, C; Di Caro, G; Diaz-Meco, MT; Febbraio, MA; Green, CR; Greten, FR; Henstridge, DC; Jain, M; Karin, M; Kisseleva, T; Knight, R; Lau, LF; Liu, X; McNulty, R; Meikle, PJ; Metallo, CM; Moranchel, R; Moscat, J; Najhawan, M; Reibe, S; Shalapour, S; Taniguchi, K; Todoric, J; Vrbanac, A; Watrous, JD | 1 |
| Sunami, Y | 1 |
| Bruno, RS; Cichon, MJ; Kopec, RE; Li, J; Sasaki, GY | 1 |
| Aghayev, M; Arias-Alvarado, A; Ilchenko, S; Kasumov, T; Lepp, J; Previs, S; Rachdaoui, N; Tsai, TH; Zhang, GF | 1 |
| Baek, IJ; Han, CY; Jang, KY; Jin, EJ; Jun, DW; Kim, PK; Park, S; Raught, B; Song, J | 1 |
| Guo, R; Liu, X; Liu, Z; Wang, Y; Wu, D; Yan, Y; Yu, Y; Zhang, W; Zhao, B | 1 |
| Browning, JD; Burgess, SC; Deja, S; Fletcher, JA; Fu, X; Satapati, S | 1 |
| Koo, SH | 1 |
2 review(s) available for acetyl coenzyme a and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling.
Topics: Acetates; Acetyl Coenzyme A; Acyltransferases; Carcinoma, Hepatocellular; Clinical Trials as Topic; Fatty Acid Desaturases; Fatty Acids; Fibrosis; Glutamine; Humans; Lipid Metabolism; Lipids; Liver Neoplasms; Metabolic Networks and Pathways; Non-alcoholic Fatty Liver Disease; Signal Transduction; Sterol Regulatory Element Binding Proteins | 2020 |
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.
Topics: Acetyl Coenzyme A; Fatty Acids; Fatty Liver; Humans; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Triglycerides | 2013 |
11 other study(ies) available for acetyl coenzyme a and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.
Topics: Acetyl Coenzyme A; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Diet, High-Fat; Epigenome; Fructose; Histones; Humans; Liver; Liver Neoplasms; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2022 |
Acetyl-CoA Deficiency Is Involved in the Regulation of Iron Overload on Lipid Metabolism in Apolipoprotein E Knockout Mice.
Topics: Acetyl Coenzyme A; Animals; Apolipoproteins E; Cholesterol; Diet, High-Fat; Iron Overload; Iron, Dietary; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease | 2022 |
Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress.
Topics: Acetyl Coenzyme A; Animals; Apoptosis; Cytosol; Endoplasmic Reticulum Stress; Female; Lipids; Mechanistic Target of Rapamycin Complex 2; Mice; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-akt | 2023 |
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Topics: Acetyl Coenzyme A; Animals; Blood Glucose; Carrier Proteins; Cell Polarity; Citric Acid; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Fasting; Gluconeogenesis; Glucose Intolerance; Hepatomegaly; Humans; Hyperglycemia; Inflammation; Insulin Resistance; Interleukin-6; Lipogenesis; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Phenotype; Time Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2020 |
Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis.
Topics: Acetyl Coenzyme A; Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Enzyme Activation; Glucagon; Gluconeogenesis; Inositol 1,4,5-Trisphosphate Receptors; Lipase; Lipolysis; Liver; Mice, Knockout; Mitochondria; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction | 2020 |
Fructose stimulated de novo lipogenesis is promoted by inflammation.
Topics: Acetyl Coenzyme A; Animals; Endotoxemia; Female; Fructose; Fructosephosphates; Gastrointestinal Microbiome; Hepatocytes; Humans; Inflammation; Intestines; Lipidomics; Lipogenesis; Macrophages; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Regeneration; Toll-Like Receptors | 2020 |
Catechin-Rich Green Tea Extract and the Loss-of-TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis.
Topics: Acetyl Coenzyme A; Animals; Arginine; Bile Acids and Salts; Catechin; Dietary Supplements; Genotype; Glutathione; Insulin Resistance; Liver; Male; Metabolome; Mice, Inbred C3H; Mice, Mutant Strains; Non-alcoholic Fatty Liver Disease; Spermidine; Tea; Toll-Like Receptor 4 | 2021 |
Measuring acetyl-CoA and acetylated histone turnover in vivo: Effect of a high fat diet.
Topics: Acetyl Coenzyme A; Acetylation; Animals; Deuterium Oxide; Diet, High-Fat; Histones; Humans; Liver; Lysine; Male; Mass Spectrometry; Mice; Non-alcoholic Fatty Liver Disease; Protein Processing, Post-Translational | 2021 |
Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue.
Topics: Acetyl Coenzyme A; Animals; Cholesterol; Diet, High-Fat; Female; Humans; Lipids; Lipogenesis; Lipolysis; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Non-alcoholic Fatty Liver Disease; PPAR alpha; Pregnancy; Thiolester Hydrolases | 2021 |
Cichoric Acid Prevents Free-Fatty-Acid-Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells.
Topics: Acetyl Coenzyme A; ARNTL Transcription Factors; Caffeic Acids; Echinacea; Fatty Acids, Nonesterified; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Plant Extracts; PPAR alpha; Signal Transduction; Succinates | 2018 |
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.
Topics: Acetyl Coenzyme A; Adult; Blood Glucose; Citric Acid Cycle; Energy Metabolism; Fasting; Female; Gluconeogenesis; Glucose Clamp Technique; Humans; Hyperglycemia; Ketone Bodies; Ketosis; Liver; Male; Middle Aged; Mitochondria; Non-alcoholic Fatty Liver Disease; Proton Magnetic Resonance Spectroscopy; Triglycerides | 2019 |